Diana Legarda

Immunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Reversal of CYLD phosphorylation as a novel therapeutic approach for adult T-cell leukemia/lymphoma (ATLL)”.

Reversal of CYLD phosphorylation as a novel therapeutic approach for adult T-cell leukemia/lymphoma (ATLL)

Cell Death and Disease(2020)10.1038/s41419-020-2294-6

N/A

0DataRank · unranked

29 citations

Matko Kalac, Michael Markson, Mark Chan, Joshua Brody, Govind Bhagat +8 more

Human TBK1 deficiency leads to autoinflammation driven by TNF-induced cell death

Cell(2021)10.1016/j.cell.2021.07.026

N/A

0DataRank · unranked

140 citations

Michael Markson, Diana Legarda, Roosheel S. Patel, Mark Chan, Louise Malle +20 more

Immune dysregulation in SHARPIN-deficient mice is dependent on CYLD-mediated cell death

Proceedings of the National Academy of Sciences(2021)10.1073/pnas.2001602118

N/A

0DataRank · unranked

16 citations

Mark Chan, Diana Legarda, John P. Sundberg, Shao‐Cong Sun, Virginia Gillespie +6 more